Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma

Journal of Gastroenterology

Volumn 34, Issue 1, 1999, Pages 83-87

  Nagao, Kumi ^a   Tomimatsu, Masahiko ^b   Endo, Hitoshi ^b   Hisatomi, Hisashi ^a   Hikiji, Kazumasa ^a  

^a SRL INC   (Japan)

^b NONE

Author keywords

Hepatocellular carcinoma; hTERT; Telomerase

Indexed keywords

MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; GENE CONTROL; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL;

EID: 0033033694     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050220     Document Type: Article

References (34)

1. Moyzis RK, Buckingham JM, Cram SH, et al. A highly conserved repetitive DNA sequence. (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988;85:6622-26.
2. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-60.
3. Hastie ND, Dempster M, Dunlop MG, et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-8.
4. Yu GL, Bradley JD, Attardi LD, et al. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 1990;344:126-32.
5. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-13.
6. Feng J, Funk WD, Wang S, et al. The RNA component of human telomerase. Science 1995;269:1236-41.
7. Hisatomi H, Ohmura Y, Nagao K, et al. Detection of telomerase RNA component in human liver tissues, Int Hepatol Commun 1997;6:175-78.
8. Meyerson M, Couter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997;90:785-95.
9. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunits homologs from fission yeast and human. Science 1997;277:955-9.
10. Suda T, Isokawa O, Aoyagi Y, et al. Quantitalion of telomerase activity in hepatocellular carcinoma: A possible aid for a prediction of recurrent diseases in the remnant liver. Hepatology 1998;27:402-6.
11. Kanamaru T, Morita Y, Ito T, et al. Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma. Jpn J Cancer Res 1998;89:727-32.
12. Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTERT in human normal oblasts and hepatocellular carcinomas. Nature Genet 1998;18:65-8.
13. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
14. Aden DP, Fogel A, Plotkin S, et al. Controlled synthesis of HBsAg in a differentiated human liver carcinoma derived cell line. Nature 1979;282:615-6.
15. Chomezynski P, Sacchi N. Single-step RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
16. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
17. Krupp G, Kuhne K, Tamm S, et al. Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust TRAP assay. Nucleic Acids Res 1997;25:919-21.
18. Kubota Y, Nakada T, Sasagawa I, et al. Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 1998;82:713-7.
19. Hisatomi H, Nagao K, Komatsu H. Quantification of telomerase activity in human liver tissues by fluorescence-based TRAP analysis. Hepatol Res 1997;7:35-42.
20. Ogino M, Hisatomi H, Hanazono M. Antitumor effect of indomethacin and telomerase activity in the tumor in colon 26 bearing CDF1 mice. Proc Jpn Acad 1997;73:150-3.
21. Holt S, Norton JC, Wright WE, et al. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci 1996;18:237-48.
22. Brein TP, Kallakury BV, Lowry CV, et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res 1997;57:2760-4.
23. Mao L, El-Naggar AK, Fan YH, et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissue. Cancer Res 1996;56:5600-4.
24. Dalbagni G, Han W, Zhang ZF, et al. Evaluation of the telomeric repeat amplification (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 1997;3:1593-8.
25. Suchara N, Mizomoto K, Muta T, et al. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Clin Cancer Res 1997;3:993-8.
26. Holt SE, Aisner DL, Shay JW, et al. Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci USA 1997;94:10687-92.
27. Blasco MA, Lee HW, Hande MP, et al. Telomerase shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997;91:25-34.
28. Aherndt SA, Yong SC, Wu L, et al. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer. Clin Cancer Res 1997;3: 1207-14.
29. Ohta K, Kanamaru T, Morita Y, et al. Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence. J Gastroenterol 1997;32:791-6.
30. Kojima H, Yokosuka O, Imazeki F, et al. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 1996;112:493-500.
31. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepalocellular carcinomas. Cancer Res 1995;55: 2734-6.
32. Nouso K, Urabe Y, Higashi T, et al. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 1996;78:232-6.
33. Ide T, Tahara H, Nakashio R, et al. Telomerase in hepatocellular carcinogenesis. Hum Cell 1996;9:283-6.
34. Okuda K, Tanaka M, Nakayama T, et al. Clinicopathologic comparision between resected hepatocellular carcinoma and recurrent tumors, Int Hepatol Commun 1993;1:65-71.